Legend Biotech Corporation
LEGN
$34.18
-$0.52-1.50%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -13.13% | 103.06% | |||
| Total Other Revenue | -88.40% | -27.22% | |||
| Total Revenue | -14.11% | 98.45% | |||
| Cost of Revenue | -7.41% | 4.74% | |||
| Gross Profit | -60.70% | 137.99% | |||
| SG&A Expenses | 21.64% | 16.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.91% | 7.85% | |||
| Operating Income | -67.63% | 64.39% | |||
| Income Before Tax | -572.71% | 69.94% | |||
| Income Tax Expenses | 1,862.39% | 4,420.00% | |||
| Earnings from Continuing Operations | -588.73% | 69.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -588.73% | 69.57% | |||
| EBIT | -67.63% | 64.39% | |||
| EBITDA | -73.45% | 65.94% | |||
| EPS Basic | -586.55% | 69.68% | |||
| Normalized Basic EPS | -570.24% | 70.28% | |||
| EPS Diluted | -583.80% | 69.56% | |||
| Normalized Diluted EPS | -570.24% | 70.28% | |||
| Average Basic Shares Outstanding | 0.37% | 0.33% | |||
| Average Diluted Shares Outstanding | 0.37% | 0.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
